menu
Home
Health Professional
Which services do you require?
ARE YOU REFERRING A PATIENT?
Which genetic test do you require?
How do I send a sample for testing?
Wales Infants & childreN's Genome Service (WINGS)
Cymru Service for Genomic Oncology Diagnoses (CYSGODI)
All Wales Psychiatric Genomics Service
PATIENT INFORMATION
Patient Information
What do we do?
What is genetics and genetic testing?
Precision, Stratified & Genomic Medicine
Genetics appointments
Cancer Genetics Service
PRENATAL GENETICS SERVICE
Haemoglobinopathy Genetics Service
Your Data - Your Rights
FREQUENTLY ASKED QUESTIONS
Relocation of AWMGS Clinical team & Associated Patient Services
Relocation Frequently Asked Questions
Laboratory Services
CONSTITUTIONAL (RARE DISEASE) SERVICES
Cancer Services
Technical Services
Pharmacogenetics
Bioinformatics
Careers
Current Vacancies
Career Pathways
CONTACT US
Clinical
Laboratory
LATEST UPDATES
The All Wales Medical Genomic Service (AWMGS) laboratory services delivers a wide range of genetic and genomic analysis services for both rare disease, cancer and pharmacogenetics to the Welsh population, UK and internationally. As part of an integrated genomic service, the laboratory also works in close collaboration with Clinical Genetics Doctors and colleagues from other disciplines, including obstetrics, paediatrics and oncology services.
The AWMGS is committed to provide a service of the highest quality.
Please use the following table to view the tests available. For ease, you can either retrieve the desired test by entering a keyword into the search box below, or select from one of the following drop down’s menus to index by test directory code (if known), ‘Speciality’, ‘Target’ (gene) and ‘method’.
Where indicated, the tests we provide which are comparable to the test directory are indicated with an ‘R’ or ‘M’ number.
'R numbers'
correspond to rare and inherited disease tests.
'M numbers'
correspond to (somatic) cancer tests.
If the test you are looking for is not shown here, it may be one that we send to a laboratory outside Wales, please
contact us
for further information.
You can find links to the NHS England Test Directory below:
Rare and inherited disease (including inherited cancers)
National genomic test directory for cancer
Search
Search
Key:
Service information sheet.
Request Form.
Additional Documentation
Service
Acute Myeloid Leukemia (AML)
All Wales Infants’ and ChildreN’s Genome Service - WINGS
Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
Angioimmunoblastic T cell lymphoma (AITCL)
BRCA1 and BRCA2 on archive tissue
Becker Muscular Dystrophy (BMD) Duchenne Muscular Dystrophy (DMD)
Bone Marrow Post Transplant Chimerism Request
Bone Marrow Pre-transplant Minisatellite Request
Breast Cancer
Breast Cancer (FISH)
Breast cancer (oncology)
CDH1-related cancer syndrome (CDH1)
CYmru Service for Genomic Oncology DIagnoses – CYSGODI
Cancer of unknown primary (CUP) - DNA
Cancer of unknown primary (CUP) - RNA
Cerebral Malformations Gene Panel
Charcot-Marie-Tooth Disease Type 1A (CMT1A Hereditary Motor and Sensory Neuropathy Type 1A, HMSN1A)
Cholangiocarcinoma
Chronic Myeloid Leukemia (CML) Service
Chronic lymphocytic Leukemia (CLL) Service
Colorectal Cancer (Circulating Tumour DNA, ctDNA)
Colorectal Cancer (DNA)
Colorectal Cancer (RNA)
Congenital Malformation Syndromes and/or Dysmorphism Service
DICER1-related cancer predisposition
DPYD pharmacogenomic testing for 5FU chemotherapy
Early Onset or Syndromic Epilepsy Gene Panel
Endocrinology - FMR1 related premature ovarian failure
Endometrial Cancer
Endometrial Cancer
Familial Melanoma
Fanconi Anemia (FA)
Fetal Anomaly Gene Panel (FAGP)
Fragile X (A) syndrome
Fragile X Tremor / Ataxia syndrome
GLIOMA (MGMT promoter hypermethylation)
Gastrointestinal Stromal Tumours (GIST) RNA
Gastrointestinal Stromal Tumours, GIST (DNA)
Glioma (DNA)
Glioma (FISH)
Glioma (RNA)
Haemato-oncology Genetic Analysis
Haemochromatosis (HFE)
Hearing - Non-syndromic Sensorineural Hearing Loss (DFNB1)
Hereditary Breast/Ovarian Cancer
Hereditary Neuropathy with Liability to Pressure Palsies (HNPP)
Huntington Disease (HD)
Immunology - Primary Immunodeficiency Disease [PID] Panel
Intellectual Disability Service
LIPIDS - Familial Hypercholesterolaemia (FH)
Legius Syndrome (NFLS, Neurofibromatosis Type 1-like Syndrome)
Li Fraumeni syndrome (TP53)
Lymphoma Service
Lynch syndrome/Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
Lynch syndrome/Hereditary Non-Polyposis Colorectal Cancer (HNPCC) follow-up
Lynch syndrome/Hereditary Non-Polyposis Colorectal Cancer (HNPCC) gene screen
Melanoma (DNA)
Myelodysplasia
Myeloma Service
Myotonic dystrophy type 1
Myotonic dystrophy type 2 (DM2)
NTRK (RNA)
Neurofibromatosis type 1 (NF1)
Next Generation Sequencing for Myeloid Malignancies
Non Small Cell Lung Cancer, NSCLC (Circulating Tumour DNA, ctDNA)
Non Small Cell Lung Cancer, NSCLC (DNA)
Non Small Cell Lung Cancer, NSCLC (FISH)
Non small cell lung cancer, NSCLC (RNA)
Non-Invasive Prenatal Testing (NIPT)
Opthamology - Leber Hereditary Optic Neuropathy (LHON)
Ovarian Cancer (blood testing)
Ovarian Cancer (tumour testing)
PTEN hamartoma syndrome (PTEN), Cowden Syndrome
Peutz-Jegher Syndrome
Pilot study – Non-Invasive-Prenatal Testing (NIPT) in pregnancies with fetal anomalies
Polyposis, including Familial Adenomatous Polyposis (FAP, AFAP) and MUTYH-associated Polyposis (MAP)
Postnatal Cytogenetic Analysis
Pregnancy Related Rapid Sequencing (R14)
Prenatal Cytogenetic Analysis
Prenatal Service: Abnormal Scan Single Nucleotide Polymorphism Array (SNP Array)
Prostate BRCA test (PARP inhibitor eligibility) - Blood
Prostate BRCA test (PARP inhibitor eligibility) - Tumour (NTRK can also be requested on this form)
QF-PCR Aneuploidy Screening
R381 - Other Rare Neuromuscular Disorders Gene Panel
R54 - Hereditary ataxia with onset in adulthood
R55 - Hereditary ataxia and cerebellar anomalies - childhood onset
R56 - Adult onset dystonia, chorea or related movement disorder
R57 - Childhood onset dystonia, chorea or related movement disorder
R58 - Adult onset neurodegenerative disorder
R60 - Adult onset hereditary spastic paraplegia
R61 - Childhood onset hereditary spastic paraplegia
R62 - Adult Onset Leukodystrophy Gene Panel
R86 - Hydrocephalus Gene Panel
Rapid BRAF testing for anaplastic thyroid carcinoma (FFPE DNA)
Rapid BRAF testing for metastatic melanoma (FFPE)
Rapid BRAF testing for metastatic melanoma (ctDNA)
Respiratory - Cystic Fibrosis (CF)
Sarcoma
Single nucleotide polymorphism (SNP) array Service for Developmental Disorders
Solid Tissue Cytogenetic Analysis
Spinal Muscular Atrophy (SMA) Type I / II / III / IV
Spinocerebellar Ataxia Type 1 / 2 / 3 / 6 / 7 / 17 (SCA1 / 2 / 3 / 6 / 7 / 17)
Systemic Mastocytosis
Thyroid (DNA)
Thyroid (RNA)
Tuberous Sclerosis Complex
Validation of copy number variants using real-time quantitative PCR (qPCR)
Waldenstrom Macroglobulinemia (WM) service / lymphoplasmacytic lymphoma
Whole Exome Sequencing for Rare Diseases (WES)
Whole Genome Sequencing for Rare Diseases (WGS)
R or M Code
M2.1, M2.5
R184.1
R77
R87
R73.2
R72.1
R410
R59
R134
R53
R402.2
R215
R213
R216
R364
R95
R68
M1.4, M1.5
R236
M1.1
R42.1
R22
R240.1, R244.1
R14
R70
R401.1, R26, R314.1
NA
R401, R22
R318, R322
M1.2, M1.3
M8.1
M4.1
M4.5
M4.2
M9.1, M10.1, M11.1, M12.1
M80.3, M82.2, M83.1
M80.2, M82.1, M85.1, M89.4
M220.6 & M220.7
M8.2
M1.5
R208
M2.1
R228
R222
R211
R212
M215.2
M94.4, M94.7, M94.8
R251.8
M92.2, M92.4, M92.5, M92.8, M92.10, M92.11, M92.12
M104.2
M95.3, M96, M97.1, M98.1, M99.1-M99.7, M101.1, M102.1, M102.2, M103.1-M103.3, M107.4, M107.5, M111.2, M182.2, 225.1,225.3
M21.21, M23.11, M27.15, M28.8, M29.8, M31.6, M32.5, M33.3, M34.7, M35.8, M36.14
M28.6, M29.5, M31.3, M32.3, M21.6, M23.8, M27.7, M34.4, M35.2, M191.12, M192.12, M193.12
M7.1, M7.2
M4.6, M4.10
M42.1, M42.2, M43.1, M45.1, M45.2, M48.1, M50.1, M56.1, M58.1, M62.1, M63.1, M63.2, M66.1, M67.1, M68.3, M74.1, M76.1, M77.1, M79.1, M196.1, M197.2, M197.3, M197.4, M197.8, M198.1, M199.3, M199.4, M199.5, M199.6, M199.7, M199.8, M199.9, M199.10, M200.2
R386
M27.6, M29.3, M31.1, M191.17, M192.17, M193.17
M21.1, M23.1, M27.1, M29.1, M31.2, M32.1, M33.3, M34.1, M35.1
M80.18, M80.21, M80.22, M80.29, M80.29, M80.41, M80.42, M80.43
R58.3
M84.1, M84.2, M84.3, M84.4
M1.6, M2.3, M215. M3.5, M4.2, M231.2, M5.2, M6.2, M7.3, M187.4, M8.2. M9.2, M9.4, M10.2, M11.4, M12.2 . M13.2, M14.4, M15.2, M15.6, M16.2, M17.2, M18.6, M217.3, M218.2, M219.2, M220.1, M221.1, M222.2, M226.1, M227.1, M20.5, M21.21, M22.9, M23.11, M24.6, M25.9, M26.4, M27.15, M28.8, M29.8, M30.4, M31.6, M32.5, M34.7, M35.8, M36.14, M37.4, M38.5, M39.4, M183.9, M184.8, M185.5, M186.8, M213.2, M189.2, M190.2, M191.21, M192.21, M193.21, M194.24, M42.5, M43.3, M45.4, M46.3, M47.3, M48.3, M49.1, M50.3, M52.3, M53.5, M55.1, M56.3, M57.1, M58.3, M60.3, M61.1, M62.3, M63.3, M64.3, M65.3, M66.3, M67.3, M68.4, M70.3, M71.3, M72.1, M73.3, M74.3, M75.3, M75.1, M76.3, M77.3, M78.1, M79.3, M196.4, M198.5, M199.2, M200.1, M201.4, M202.7, M203.6, M204.6, M205.8, M206.8, M207.7, M208.1, M209.5, M210.1, M211.4, M85.3, M119.2, M120.6, M124.10, M126.3, M127.4, M195.4, M130.5, M131.5, M132.2, M133.4, M136.3, M137.2, M138.3, M139.2, M143.5, M145.14, M146.7, M147.8, M148.9, M149.3, M150.8, M151.6, M152.16, M153.5, M155.4, M156.9, M157.3, M158.6, M159.6, M160.2, M161.5, M162.9, M165.7, M212.15, M166.3, M167.5, M168.6, M169.5, M170.7, M171.8, M172.7, M173.3, M174.4, M178.4, M179.10, M180.7
M1.6
R21
R337.1
M86.2
R29
R297, R265, R314, R146
M215.5
M3.6
M111.1
R27, R29, WINGS/R14
R27, R29
R27
R254
R210
n/a
M3.2, M3.3, M3.4
R208 R444.1
M226.4
M82
M9.2, M10.2, M11.4, M12.2
R444.2
M218.1
R381
R62
R86
R55
R56
R57
R58
R60
R61
R54
Speciality
Oncology
Specialist Rare Disease
Neurology
Developmental Delay
Cancer Genetics
Haematology
Prenatal
Acutely Unwell Children
Pharmacogenomics
Pathology
Core Rare Disease
Rare Disease
Haematological Malignancy
Method
DNA NGS panel or Myriad HRD testing
Targeted Testing
MLPA or equivalent
Large Panel
Single gene sequencing and CNV analysis
STR testing
Small panel
DNA NGS Panel
Targeted mutation testing
Microsatellite instability or IHC
Single gene sequencing, MLPA
Whole Genome Sequencing
Common aneuploidy testing
Massively Parallel Shotgun Sequencing
Common aneuploidy testing Microarray
Simple Targeted Mutation Testing
DNA Panel
Panel Simple targeted mutation testing FISH/Simple targeted mutation testing
DNA Panel, Pyrosequencing
Karyotype or equivalent
FISH & DNA NGS Panel
RNA Panel
Pyrosequencing
FISH, Single Gene Sequencing
Cytogenetics
FISH
FISH, complex targeted mutation testing
DNA panel, simple targeted mutation testing
DNA, RNA
DNA, Cytogenetics
RNA
RNA NGS Panel
Whole Exome Sequencing
SNP Array
Whole Exome Sequencing, Whole Genome Sequencing
Karyotype Common aneuploidy testing Microarray
DNA NGS Panel (Small Variant Detection)
Whole Genome Sequencing, Whole Exome Sequencing
ctDNA Pyrosequencing (BRAF only)
FFPE Pyrosequencing (BRAF only)
Target Gene
BRCA1/2 and/or Genomic Instability
CFTR 8 common Welsh variants, CFTR 50 common European variants *Please note CF50 tests are currently being referred to an external lab until 30/11/23
PMP22
Cortical Malformation Syndromes
GJB2 sequencing and GJB6 deletions
DMD
DMPK STR
CNBP (ZNF9) STR
Infantile Epilepsy Syndromes
Familial hypercholesterolaemia – targeted panel (772)
FMR1 STR
CDH1
PTEN
TP53
DICER1
HFE common variants
HTT STR
MSI or MMR (MLH1, MSH2, MSH6, PMS2) deficiency
SPRED1
KRAS, NRAS, BRAF, PTEN, PIK3CA, TP53, EGFR
Three common LHON variants
Primary Immunodeficiency Disorders
Specific Target
Paediatric Disorders
ATXN1, ATXN2, ATXN3, CACNA1A, ATXN7, TBP
SMN1
Genomewide Sex chromosomes
Chromosomes 13, 18 and 21
Genomewide
DPYD
KRAS, NRAS
KIT, PDGFRA
EGFR, ALK, BRAF, KRAS ROS1, RET, ELM4-ALK, NTRK1, NTRK2, NTRK3
EGFR
ALK, ROS1, RET, MET, EGFR, NTRK 1, NTRK 2, NTRK 3
BRAF, KRAS, NRAS, HRAS RET TP53
Detection of Complex karyotype, Monosomal karyotype and structural rearrangements
ASXL1, BCOR, CALR, CEBPA, CBL, DNMT3A, EZH2, ETV6, FLT3, GATA2, IDH1, IDH2, JAK2, KRAS, KIT, MPL, NRAS, NPM1, NOTCH1, PDGFRA, RUNX1, SF3B1, SRSF2, SETBP1, TET2, TP53, U2AF1
FGFR2 & IDH1
NTRK1, NTRK2, NTRK3
BRAF hotspot, MLH1 Promoter hypermethylation
BRCA1, BRCA2, PALB2, PTEN, STK11, TP53
BRCA1, BRCA2
TSC1, TSC2
NF1
APC, MUTYH, BMPR1A, SMAD4, POLD1, POLE
STK11
MLH1 promoter hypermethylation
ATM, TP53
DNA repair defects in the FA genes
TP53, IGH, MAF, CCND1, FGFR3, CDKN2C, CKS1B
MYD88
MYC, BCL2, BCL6, 11q MYC-IGH, MYC-IGK MYC-IGL, IGH-BCL2, IGH-CCND1, P53-CEN17 ALK, IRF4, TP63, DUSP22, TCRB, TCRG, MALT
BRAF, EGFR, NTRK1,2,3
1p19q
BRAF, KIT, NRAS
ALK, ROS1 (Confirmation of IHC results by prior arrangement)
PAX3-FOXO1,TFE3, EWSR1, COL1A1-PDGFB, NR4A3, ETV6-NTRK3, TPM4-ALK, TPM3-ALK, EWSR1, DDIT3, MDM2, MYC, FUS, SS18. FOXO1, USP6
MGMT
IDH1, IDH2, BRAF, EGFR, ATRX, H3-3A, TERT, PTEN, TP53, CDKN2A
CBFB-MYHII, RUNX1-RUNX1T1, FLT3-ITD, FLT3-TKD, NPM1, ASXL1, BCOR, CALR, CEBPA, CBL, DNMT3A, EZH2, ETV6, FLT3, GATA2, IDH1, IDH2, JAK2, KRAS, KIT, MPL, NRAS, NPM1, NOTCH1, PDGFRA, RUNX1, SF3B1, SRSF2, SETBP1, TET2, TP53, U2AF1
C9ORF72
BCR-ABL1
Fetal Anomalies Disorders
Whole genome CNV
cKIT
Intellectual Disability Related Disorders
As determined by indication Genomewide Sex chromosomes
POLE, (TP53 optional)
PIK3CA
DNMT3A, TET2, IDH2, RHOA
Congenital Malformation Syndromes and/or Dysmorphism Related Disorders
CDKN2A, CDK4 and BAP1
MLH1, MSH2, MSH6
BRAF
HER2
BRCA1, BRCA2, PALB2, ATM, CHEK2, RAD51C, RAD51D
Androgen receptor, ARID1A, ATRX, BRAF, BRCA1, BRCA2, CDKN2A, EGFR, ESR1, ERBB2, H3F3A, HRAS, IDH1, IDH2, KIT, KRAS, NRAS, PDGFRA, PIK3CA, PTEN, RET, TERT, TP53
ALK, BRAF, EGFR, MET, NTRK1, NTRK2, NTRK3, RET, ROS1
NTRK1, NTRK2, NTRK3, RET, EGFR
Other Rare Neuromuscular Disorders
Adult Onset Leukodystrophy
Hydrocephalus
Hereditary ataxia and cerebellar anomalies - childhood onset
Adult onset dystonia, chorea or related movement disorder
Childhood onset dystonia, chorea or related movement disorder
Adult onset neurodegenerative disorder
Adult onset hereditary spastic paraplegia
Childhood onset hereditary spastic paraplegia
Hereditary ataxia with onset in adulthood
Filter by category
Service
R or M Code
Speciality
Method
Target Gene
Download
Upload file 3
Upload file 4
Upload file 5
Start
Prev.
1
2
3
Next
End
Li Fraumeni syndrome (TP53)
R216
Cancer Genetics
DNA NGS Panel
TP53
LIPIDS - Familial Hypercholesterolaemia (FH)
R134
Specialist Rare Disease
Small panel
Familial hypercholesterolaemia – targeted panel (772)
Lymphoma Service
M95.3, M96, M97.1, M98.1, M99.1-M99.7, M101.1, M102.1, M102.2, M103.1-M103.3, M107.4, M107.5, M111.2, M182.2, 225.1,225.3
Haematology
FISH, complex targeted mutation testing
MYC, BCL2, BCL6, 11q MYC-IGH, MYC-IGK MYC-IGL, IGH-BCL2, IGH-CCND1, P53-CEN17 ALK, IRF4, TP63, DUSP22, TCRB, TCRG, MALT
Lynch syndrome/Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
M1.4, M1.5
Oncology
Microsatellite instability or IHC
MSI or MMR (MLH1, MSH2, MSH6, PMS2) deficiency
Lynch syndrome/Hereditary Non-Polyposis Colorectal Cancer (HNPCC) follow-up
M1.5
Pathology
Pyrosequencing
BRAF hotspot, MLH1 Promoter hypermethylation
Lynch syndrome/Hereditary Non-Polyposis Colorectal Cancer (HNPCC) gene screen
R210
Oncology
DNA NGS panel
MLH1, MSH2, MSH6
Melanoma (DNA)
M7.1, M7.2
Oncology
DNA panel, simple targeted mutation testing
BRAF, KIT, NRAS
Myelodysplasia
M82
Haematological Malignancy
Myeloma Service
M92.2, M92.4, M92.5, M92.8, M92.10, M92.11, M92.12
Haematology
FISH
TP53, IGH, MAF, CCND1, FGFR3, CDKN2C, CKS1B
Myotonic dystrophy type 1
R72.1
Neurology
STR testing
DMPK STR
Myotonic dystrophy type 2 (DM2)
R410
Neurology
STR testing
CNBP (ZNF9) STR
Neurofibromatosis type 1 (NF1)
R222
Cancer Genetics
DNA NGS panel
NF1
Next Generation Sequencing for Myeloid Malignancies
M80.2, M82.1, M85.1, M89.4
Haematology
ASXL1, BCOR, CALR, CEBPA, CBL, DNMT3A, EZH2, ETV6, FLT3, GATA2, IDH1, IDH2, JAK2, KRAS, KIT, MPL, NRAS, NPM1, NOTCH1, PDGFRA, RUNX1, SF3B1, SRSF2, SETBP1, TET2, TP53, U2AF1
Non Small Cell Lung Cancer, NSCLC (Circulating Tumour DNA, ctDNA)
M4.5
Oncology
Simple targeted mutation testing
EGFR
Non Small Cell Lung Cancer, NSCLC (DNA)
M4.1
Oncology
DNA Panel
EGFR, ALK, BRAF, KRAS ROS1, RET, ELM4-ALK, NTRK1, NTRK2, NTRK3
Non Small Cell Lung Cancer, NSCLC (FISH)
M4.6, M4.10
Oncology
FISH
ALK, ROS1 (Confirmation of IHC results by prior arrangement)
Non small cell lung cancer, NSCLC (RNA)
M4.2
Oncology
Panel Simple targeted mutation testing FISH/Simple targeted mutation testing
ALK, ROS1, RET, MET, EGFR, NTRK 1, NTRK 2, NTRK 3
Non-Invasive Prenatal Testing (NIPT)
NA
Prenatal
Massively Parallel Shotgun Sequencing
Chromosomes 13, 18 and 21
NTRK (RNA)
M1.6, M2.3, M215. M3.5, M4.2, M231.2, M5.2, M6.2, M7.3, M187.4, M8.2. M9.2, M9.4, M10.2, M11.4, M12.2 . M13.2, M14.4, M15.2, M15.6, M16.2, M17.2, M18.6, M217.3, M218.2, M219.2, M220.1, M221.1, M222.2, M226.1, M227.1, M20.5, M21.21, M22.9, M23.11, M24.6, M25.9, M26.4, M27.15, M28.8, M29.8, M30.4, M31.6, M32.5, M34.7, M35.8, M36.14, M37.4, M38.5, M39.4, M183.9, M184.8, M185.5, M186.8, M213.2, M189.2, M190.2, M191.21, M192.21, M193.21, M194.24, M42.5, M43.3, M45.4, M46.3, M47.3, M48.3, M49.1, M50.3, M52.3, M53.5, M55.1, M56.3, M57.1, M58.3, M60.3, M61.1, M62.3, M63.3, M64.3, M65.3, M66.3, M67.3, M68.4, M70.3, M71.3, M72.1, M73.3, M74.3, M75.3, M75.1, M76.3, M77.3, M78.1, M79.3, M196.4, M198.5, M199.2, M200.1, M201.4, M202.7, M203.6, M204.6, M205.8, M206.8, M207.7, M208.1, M209.5, M210.1, M211.4, M85.3, M119.2, M120.6, M124.10, M126.3, M127.4, M195.4, M130.5, M131.5, M132.2, M133.4, M136.3, M137.2, M138.3, M139.2, M143.5, M145.14, M146.7, M147.8, M148.9, M149.3, M150.8, M151.6, M152.16, M153.5, M155.4, M156.9, M157.3, M158.6, M159.6, M160.2, M161.5, M162.9, M165.7, M212.15, M166.3, M167.5, M168.6, M169.5, M170.7, M171.8, M172.7, M173.3, M174.4, M178.4, M179.10, M180.7
Oncology
RNA
NTRK1, NTRK2, NTRK3
Opthamology - Leber Hereditary Optic Neuropathy (LHON)
R42.1
Specialist Rare Disease
Targeted mutation testing
Three common LHON variants
Ovarian Cancer (blood testing)
M2.1
Oncology
DNA NGS Panel
BRCA1, BRCA2
Ovarian Cancer (tumour testing)
M2.1, M2.5
Oncology
DNA NGS panel or Myriad HRD testing
BRCA1/2 and/or Genomic Instability
Peutz-Jegher Syndrome
R212
Cancer Genetics
DNA NGS panel
STK11
Pilot study – Non-Invasive-Prenatal Testing (NIPT) in pregnancies with fetal anomalies
Prenatal
Massively Parallel Shotgun Sequencing
Chromosomes 13, 18 and 21
Polyposis, including Familial Adenomatous Polyposis (FAP, AFAP) and MUTYH-associated Polyposis (MAP)
R211
Cancer Genetics
DNA NGS panel
APC, MUTYH, BMPR1A, SMAD4, POLD1, POLE
Postnatal Cytogenetic Analysis
R297, R265, R314, R146
Developmental Delay
Karyotype Common aneuploidy testing Microarray
As determined by indication Genomewide Sex chromosomes
Pregnancy Related Rapid Sequencing (R14)
R14
Core Rare Disease
Whole Genome Sequencing, Whole Exome Sequencing
Paediatric Disorders
Prenatal Cytogenetic Analysis
R401, R22
Prenatal
Common aneuploidy testing Microarray
Genomewide
Prenatal Service: Abnormal Scan Single Nucleotide Polymorphism Array (SNP Array)
R22
Prenatal
Prostate BRCA test (PARP inhibitor eligibility) - Blood
R444.2
Oncology
DNA NGS panel
BRCA1, BRCA2
Prostate BRCA test (PARP inhibitor eligibility) - Tumour (NTRK can also be requested on this form)
M218.1
Oncology
DNA NGS panel
BRCA1, BRCA2
PTEN hamartoma syndrome (PTEN), Cowden Syndrome
R213
Cancer Genetics
DNA NGS Panel
PTEN
QF-PCR Aneuploidy Screening
R401.1, R26, R314.1
Prenatal
Common aneuploidy testing
Genomewide Sex chromosomes
R381 - Other Rare Neuromuscular Disorders Gene Panel
R381
Neurology
Large Panel
Other Rare Neuromuscular Disorders
R54 - Hereditary ataxia with onset in adulthood
R54
Neurology
Large Panel
Hereditary ataxia with onset in adulthood
R55 - Hereditary ataxia and cerebellar anomalies - childhood onset
R55
Neurology
Large Panel
Hereditary ataxia and cerebellar anomalies - childhood onset
R56 - Adult onset dystonia, chorea or related movement disorder
R56
Neurology
Large Panel
Adult onset dystonia, chorea or related movement disorder
R57 - Childhood onset dystonia, chorea or related movement disorder
R57
Neurology
Large Panel
Childhood onset dystonia, chorea or related movement disorder
R58 - Adult onset neurodegenerative disorder
R58
Neurology
Large Panel
Adult onset neurodegenerative disorder
R60 - Adult onset hereditary spastic paraplegia
R60
Neurology
Large Panel
Adult onset hereditary spastic paraplegia
R61 - Childhood onset hereditary spastic paraplegia
R61
Neurology
Large Panel
Childhood onset hereditary spastic paraplegia
R62 - Adult Onset Leukodystrophy Gene Panel
R62
Neurology
Large Panel
Adult Onset Leukodystrophy
R86 - Hydrocephalus Gene Panel
R86
Neurology
Large Panel
Hydrocephalus
Rapid BRAF testing for anaplastic thyroid carcinoma (FFPE DNA)
n/a
Oncology
FFPE Pyrosequencing (BRAF only)
BRAF
Rapid BRAF testing for metastatic melanoma (ctDNA)
n/a
Oncology
ctDNA Pyrosequencing (BRAF only)
BRAF
Rapid BRAF testing for metastatic melanoma (FFPE)
n/a
Oncology
FFPE Pyrosequencing (BRAF only)
BRAF
Respiratory - Cystic Fibrosis (CF)
R184.1
Specialist Rare Disease
Targeted Testing
CFTR 8 common Welsh variants, CFTR 50 common European variants *Please note CF50 tests are currently being referred to an external lab until 30/11/23
Sarcoma
M42.1, M42.2, M43.1, M45.1, M45.2, M48.1, M50.1, M56.1, M58.1, M62.1, M63.1, M63.2, M66.1, M67.1, M68.3, M74.1, M76.1, M77.1, M79.1, M196.1, M197.2, M197.3, M197.4, M197.8, M198.1, M199.3, M199.4, M199.5, M199.6, M199.7, M199.8, M199.9, M199.10, M200.2
Pathology
FISH
PAX3-FOXO1,TFE3, EWSR1, COL1A1-PDGFB, NR4A3, ETV6-NTRK3, TPM4-ALK, TPM3-ALK, EWSR1, DDIT3, MDM2, MYC, FUS, SS18. FOXO1, USP6
Single nucleotide polymorphism (SNP) array Service for Developmental Disorders
R337.1
Developmental Delay
SNP Array
Whole genome CNV
Solid Tissue Cytogenetic Analysis
R318, R322
Prenatal
Common aneuploidy testing Microarray
Genomewide